Koushik Yetukuri

Dr. Koushik Yetukuri

Chalapathi Institute of Pharmaceutical Sciences, Guntur, India
orcid
Associate Professor, Department of Regulatory Affairs

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2025 in Gels
Verified
Journal Article
Open access
PDF file
Koushik YetukuriKoushik Yetukuri
Koushik Yetukuri
UMUmashankar M.S
Umashankar M.S
This study investigates the Quality by Design (QbD)-driven development and optimization of a nanoemulgel incorporating Kunzea ericoides oil for transdermal therapy. Nanoemulgels enhance percutaneous drug delivery, sustain release profiles, and improve bioavailability. A central composite design was employed to optimize critical formulation parameters, with ANOVA confirming a statistically significant impact on particle size and drug release kinetics (p < 0.05). The optimized formulation exhibited a particle size of 112.38 nm, a polydispersity index of 0.203, and a zeta potential of −29.0 mV, ensuring colloidal stability. In vitro drug release followed the Higuchi model (R2 = 0.989, kH = 4.776), indicating diffusion-controlled kinetics, while the Korsmeyer–Peppas model (n = 0.88) suggested an anomalous transport mechanism. Antibacterial studies determined minimum inhibitory concentrations of 250 µg/mL for Staphylococcus aureus and 500 µg/mL for Escherichia coli, indicating greater susceptibility in S. aureus. In vivo anti-inflammatory evaluation using a carrageenan-induced paw edema model demonstrated a statistically significant reduction in inflammation (p = 0.005 at 60 min), with a near-complete resolution by 240 min. These findings underscore the potential of Kunzea ericoides nanoemulgel as a promising transdermal therapeutic, integrating controlled drug release with potent anti-inflammatory and antibacterial properties for dermatological and inflammatory conditions.

26 September 2025 in Gels
Verified
Journal Article
Open access
PDF file
Koushik YetukuriKoushik Yetukuri
Koushik Yetukuri
RNRama Rao Nadendla
Rama Rao Nadendla
Uriti Sri VenkateshUriti Sri Venkatesh
Uriti Sri Venkatesh
VRVenkata Rami Reddy
Venkata Rami Reddy
SVSurendra Venkata
Surendra Venkata
Sreenu ThallaSreenu Thalla
Sreenu Thalla
This study reports the development and optimization of a Melissa officinalis oil-based nanoemulgel for transdermal delivery using a Design-of-Experiments (DoE) approach. A Central Composite Design (CCD) was applied to optimize Tween 80 concentration and homogenization time, resulting in a nanoemulsion with a droplet size of 127.31 nm, PDI of 17.7%, and zeta potential of −25.0 mV, indicating good colloidal stability. FTIR analysis confirmed the presence of functional groups such as O–H, C=O, and C–O–C, supporting the oil’s phytochemical richness and therapeutic potential. DSC analysis revealed enhanced thermal stability and successful encapsulation, while SEM imaging showed a uniform and spherical microstructure. The drug release followed Higuchi kinetics (R2 = 0.900), indicating diffusion-driven release, with the Korsmeyer–Peppas model (n = 0.88) suggesting anomalous transport. Antibacterial studies showed inhibition of Staphylococcus aureus (MIC = 250 µg/mL) and Escherichia coli (MIC = 500 µg/mL). In vivo anti-inflammatory testing demonstrated significant edema reduction (p < 0.05) using a carrageenan-induced rat paw model. These results support the potential of Melissa nanoemulgel as a stable and effective topical therapeutic for inflammatory and microbial skin disorders.

26 August 2024 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
Koushik YetukuriKoushik Yetukuri
Koushik Yetukuri
UMUmashankar M.S
Umashankar M.S
The global demand for essential oils is expanding as a result of their numerous applications and increasing consumer exposure in the international market. Essential oils (EOs) are mixtures of volatile compounds including, but not limited to, phenolics, esters, ketones, terpenes, alcohols, and amides. The majority of EOs have excellent antioxidant, antibacterial, and functional activities. These natural products have conquered space in the food, drug, and cosmetic commercial arena. Unfortunately, like many lipophilic and aromatic active substances, EO presents some drawbacks such as low water solubility, strong organoleptic characteristics, low stability, and limited administration routes, which confines their Industrial use. EOs can be nanoencapsulated to increase their persistence, and bioavailability in the biological process by employing the optimum encapsulation polymers. Additionally, these particles are capable of controlling the release of the EOs promoting a prolonged preservative effect in cosmetics and foods, as well as a potential advantage for pharmaceutical dosage forms. The current research focuses on the essential features of EOs as well as their encapsulation methods. Furthermore, the potential applications of applying nanoencapsulated essential oils in the healthcare field were addressed.

30 June 2022 in International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN)
Verified
Journal Article
Closed access
PDF file
Koushik YetukuriKoushik Yetukuri
Koushik Yetukuri
UMUmashankar M.S.
Umashankar M.S.
Essential oils have been used for virucidal, bactericidal, fungicidal, antiparasitic, insecticidal, and other therapeutic properties like analgesic, sedative, spasmolytic, anti-inflammatory, and locally anaesthetic remedies since the Medieval Era. Essential oils are complex mixtures of a variety of volatile molecules which includes terpenoids, phenol-derived aromatic components, and aliphatic components. These molecules are used in the pharmacological, cosmetic, sanitary, food, and agricultural sectors for multiple applications. The stability and bioactivity of essential oils, on the other hand, impact their efficacy. The ultrasonication procedure is one of the most effective ways to preserve essential oils. Improved water solubility, effective degradation protection, and the prevention of volatile component evaporation are just a few of the benefits. This article focuses on nanotechnology's most significant contributions to essential oils formulated using the Ultrasonication process. The chemical makeup of essential oils, the Ultrasonication technique's basis, the physicochemical characteristics of nanoformulation loaded with essential oil, and their contemporary uses are all highlighted. Essential oils can perform better than chemically synthesized drugs. As compared to certain other formulation techniques, oil nanoencapsulation has been noted as a cost-effective approach, and the ultrasonication approach is a simpler, less energy-consuming, more repeatable, and broadly valid method for the encapsulation of essential oils.

15 December 2020 in International Journal of Drug Regulatory Affairs
Verified
Journal Article
Open access
SSSri Lakshmi Sowjanya Reddy Singam
Sri Lakshmi Sowjanya Reddy Singam
Koushik YetukuriKoushik Yetukuri
Koushik Yetukuri
RNRama Rao Nadendla
Rama Rao Nadendla
Registration of pharmaceutical drug products in emerging market is maximum worrying task. Although the requirements are harmonized in regulated international locations by way of CTD (Common technical document) submitting, yet others have considerable diversity in necessities. International conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) has brought regulatory authorities and pharmaceutical industries of US, Japan and Europe collectively for various factors of drug registration. But there is no such harmonized guideline for rising marketplace besides Association of Southeast Asian Nations (ASEAN) and Gulf Co-operation Council (GCC) where harmonization exists in clusters with their mutual situation. Quality, Safety and Efficacy information has significance importance in dossier registration. Pharmaceutical Industries has to conform with regulatory requirement in Emerging market and for betterment of public Health and protection. The business importance of markets is increasing globally. It is important for pharmaceutical enterprise to address the regulatory necessities for betterment of public and to ensure their place in the marketplace. The review additionally explains a short approximately extraordinary regulatory requirement for Registration of drug product in Emerging market and comparative data for registration of dossier software in Emerging marketplace.

30 November 2013 in International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN)
Verified
Journal Article
Closed access
PDF file
RTR S Thakur
R S Thakur
ANA Nayaz
A Nayaz
Koushik YetukuriKoushik Yetukuri
Koushik Yetukuri
In the case of solubility limited absorption, creating supersaturation in the GI fluid is very critical as supersaturation may provide great improvement of oral absorption. The techniques to create the so-called supersaturation in the GI fluid include microemulsions, emulsions, liposomes, complexations, polymeric micelles, and conventional micelles. Ciprofloxacin was chosen because it is practically insoluble in water; hence its salt form is used commercially, which is soluble in water. The objective of the present investigation was to enhance the solubility of Ciprofloxacin by formulating it into microemulsion system. For this purpose, initially, surfactant and cosurfactant were selected based on their HLB value, followed by pseudo-ternary phase diagrams to identify the microemulsion existing zone. Different formulations were developed and evaluated for pH, conductivity, in vitro release and stability. Solubility study was performed for optimized formulation. The pH of the designed formulations varied from 6.02-7.04. This was ideal and near blood pH 7.4. Conductivity data indicated that the microemulsion was of the o/w type. In vitro release of optimized formulation(FM3) was 95.2% as compared to pure drug 46.61% after 90 min and marketed product(salt form) 93.9%. Hence, by formulating into microemulsion, the solubility of ciprofloxacin is significantly enhanced.